NCT05301517Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Study sponsor: Kyntra Bio

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-04-03Actual
Enrollment · participants159Actual
Source updated2023-06-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview